Vantage logo

The US FDA plays it safe

Amid a huge furore over unsafe implanted medical devices the US FDA has released new proposals that are cautious to the point of toothlessness – and wouldn’t affect most…

Vantage logo

Esmo 2018 – Loxo sees off Roche 

The first look at data from Roche’s tumour-agnostic project entrectinib look good, but not good enough to unseat Loxo and Bayer’s larotrectinib.